Plans for Translation of the Evidence Report into Derivative Products

EPCs take approximately one year to produce evidence reports/technology assessments. Organizations that nominate topics are responsible for translating the evidence reports and/or technology assessments into products that are useful for their memberships or other target groups. Please describe your plans for translating the evidence reports into quality improvement tools (e.g., clinical practice guidelines, performance measures), educational programs and/or coverage or reimbursement policies.

Plans for Dissemination of These Derivative Products to its Membership

Organizations nominating topics are responsible for disseminating the derivative products to their memberships or other target groups, as appropriate. Please describe your organization’s plans for disseminating these quality improvement tools (e.g., clinical practice guidelines, performance measures), educational programs, etc. Please include a description of the target groups of these products (e.g., organizational members, health professionals, patient/consumer groups, regulators, etc.), proposed dissemination media (e.g., journal articles, print media, Internet), and timeframe for dissemination.

How Organization will Measure Use of the Products and Impact of Such Use

Organizations nominating topics are responsible for measuring the use of the derivative products and their impact. Please describe the process by which your organization will measure the use of the products and the impact of such use on clinical care. In addition, briefly describe any barriers to use or implementation of the derivative products (e.g., lack of funding, lack of patient compliance, professional resistance) and possible means to overcome these barriers (e.g., continuing education, changes in payment policies).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement